Budget Impact Models

Budget Impact Models

The RXA Budget Impact Model enables pharmaceutical companies to use the NHS’s own data to produce realistic and plausible cost saving prescribing switch strategies.

With the RXA Budget Impact model you can:

  • Create summary overviews at annual and portfolio levels
  • Drill down to underlying detailed product-specific calculations
  • Use tables, charts and maps in the purpose-built dashboard to provide extensive, highly visual and easy to interpret analytics
  • Make on the spot adjustments of model parameters – (E.g. switch %) via slider controls
  • Automatically rank the top ‘X’ GP practices to target
  • Create outputs to leave behind after meetings – Including CCG or GP practice level branded reports containing details of identified cost savings
We make analytics simple
Request your demonstration today

“Obviously I wouldn’t recommend Rx Analyser to our direct competitors as I believe the level of insight provided really gives us an edge.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“Customers tell us our platform has changed the way they work, that they’ve enhanced the strategies they implement, based on the work they’ve done with the analyser tool and that – bottom line – we’ve helped them to increase their sales. That’s a pretty good result from a chance cup of coffee.”

Andrew Norman and David Warwick, Directors

“Our sales team use RX Analyser to analyse results and opportunity; it’s used by management to measure performance and identify national trends to drive targeting and strategy.”

National Sales Manager, UK Pharmaceutical Company

“Export to Excel is straightforward, which facilitates easy manipulation if required, for example, for territory planning.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“Rx Analyser is already having a significant impact on our business, allowing our Territory Managers to focus on established CCG accounts and identify practice level successes and others for further development.”

Managing Director, UK Diabetes Healthcare Company

“Key benefits? Adaptability, flexibility for future changes and cloud-based.”

General Manager, Global Healthcare Company

Sign up for added insights